Antoni Jou

1.8k total citations
23 papers, 904 citations indexed

About

Antoni Jou is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Antoni Jou has authored 23 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 10 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Antoni Jou's work include HIV Research and Treatment (13 papers), HIV/AIDS Research and Interventions (8 papers) and Hepatitis C virus research (8 papers). Antoni Jou is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS Research and Interventions (8 papers) and Hepatitis C virus research (8 papers). Antoni Jou collaborates with scholars based in Spain, United States and Belgium. Antoni Jou's co-authors include Bonaventura Clotet, Joan Romeu, Anna Bonjoch, Cristina Tural, Eugènia Negredo, Montserrat Balagué, Roger Paredes, Carmina R. Fumaz, Lı́dia Ruiz and Guillem Sirera and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Antoni Jou

23 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antoni Jou Spain	15	543	484	339	232	112	23	904
Anna Danise Italy	13	382 0.7×	289 0.6×	128 0.4×	104 0.4×	13 0.1×	24	504
M Battegay Switzerland	9	553 1.0×	433 0.9×	288 0.8×	173 0.7×	120 1.1×	14	747
Monica Airoldi Italy	11	525 1.0×	349 0.7×	218 0.6×	167 0.7×	36 0.3×	27	728
Cristina Mussini Italy	11	336 0.6×	229 0.5×	184 0.5×	112 0.5×	19 0.2×	27	484
Kathleen Squires United States	11	432 0.8×	325 0.7×	267 0.8×	263 1.1×	93 0.8×	17	817
P. de Truchis France	10	351 0.6×	251 0.5×	201 0.6×	147 0.6×	32 0.3×	20	589
Peter Gute Germany	18	868 1.6×	688 1.4×	308 0.9×	216 0.9×	56 0.5×	35	1.2k
Burc Barin United States	15	514 0.9×	96 0.2×	364 1.1×	42 0.2×	33 0.3×	32	723
Elżbieta Bąkowska Poland	8	313 0.6×	225 0.5×	177 0.5×	199 0.9×	52 0.5×	18	512
Olayemi Osiyemi United States	16	762 1.4×	478 1.0×	187 0.6×	285 1.2×	10 0.1×	37	879

Countries citing papers authored by Antoni Jou

Since Specialization

Citations

This map shows the geographic impact of Antoni Jou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoni Jou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoni Jou more than expected).

Fields of papers citing papers by Antoni Jou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoni Jou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoni Jou. The network helps show where Antoni Jou may publish in the future.

Co-authorship network of co-authors of Antoni Jou

This figure shows the co-authorship network connecting the top 25 collaborators of Antoni Jou. A scholar is included among the top collaborators of Antoni Jou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoni Jou. Antoni Jou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

López-Núñez, Juan J., Núria Pérez‐Álvarez, Antoni Jou, et al.. (2017). Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV‐Coinfected Patients in Clinical Practice. Journal of Ultrasound in Medicine. 37(1). 113–121. 3 indexed citations

Morón‐López, Sara, María Salgado, Dan Ouchi, et al.. (2015). Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4⁺T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy. The Journal of Infectious Diseases. 213(6). 1008–1012. 30 indexed citations

Macı́as, Juan, Juan González, Cristina Tural, et al.. (2014). Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients. AIDS. 28(9). 1279–1287. 60 indexed citations

Montes, Marisa, José M. Miró, Carmen Quereda, et al.. (2013). Incidence of Hepatocellular Carcinoma in HIV-Infected Patients With Cirrhosis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(1). 82–86. 11 indexed citations

Echeverría, Patricia, Anna Bonjoch, José Moltó, et al.. (2013). Pulse Wave Velocity as Index of Arterial Stiffness in HIV-Infected Patients Compared With a Healthy Population. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(1). 50–56. 24 indexed citations

Negredo, Eugènia, Marta Massanella, María C. Puertas, et al.. (2013). Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 68(10). 2358–2362. 25 indexed citations

Tor, Jordi, Arantza Sanvisens, Antoni Jou, et al.. (2013). Progression of liver fibrosis inHIV/hepatitisCvirus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline. HIV Medicine. 15(4). 203–212. 17 indexed citations

Tor, Jordi, Roberto Muga, Antoni Jou, et al.. (2012). Effect of Liver Fibrosis on Long-Term Mortality in HIV/Hepatitis C Virus-Coinfected Individuals Who Are Evaluated to Receive Interferon Therapies in the Highly Active Antiretroviral Therapy Era. AIDS Research and Human Retroviruses. 28(10). 1235–1243. 6 indexed citations

Eynde, Eva Van den, Juan Tiraboschi, Cristina Tural, et al.. (2010). Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients. AIDS. 24(7). 975–982. 8 indexed citations

10.

Jou, Antoni, Cecilia Cabrera, Francesc E. Borràs, et al.. (2010). Distribution of CD31 on CD4 T-Cells from Cord Blood, Peripheral Blood and Tonsil at Different Stages of Differentiation~!2009-11-24~!2009-12-24~!2010-03-05~!. 3(1). 19–26. 4 indexed citations

11.

Massanella, Marta, Cristina Tural, Laura Papagno, et al.. (2009). Changes in T-cell subsets in HIV–HCV-coinfected patients during pegylated interferon-α2a plus ribavirin treatment. Antiviral Therapy. 15(3). 333–342. 14 indexed citations

12.

Negredo, Eugènia, Luís A. B. Cruz, Roger Paredes, et al.. (2002). Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression. Clinical Infectious Diseases. 34(4). 504–510. 123 indexed citations

13.

Tuldrà, Albert, Carmina R. Fumaz, Ramón Bayés, et al.. (2000). Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(3). 221–228. 197 indexed citations

14.

Romeu, Joan, G. Sirera, Moacyr Jesus Barreto de Melo Rêgo, et al.. (1999). Cumulative risk for developing hyperlipidemia in HIV-infected patients treated with protease inhibitors. 39. 498. 11 indexed citations

15.

Paredes, Roger, Teresa Puig, Eugènia Negredo, et al.. (1999). High-Dose Saquinavir Plus Ritonavir: Long-Term Efficacy in HIV-Positive Protease Inhibitor–Experienced Patients and Predictors of Virologic Response. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(2). 132–132. 17 indexed citations

16.

Blanco, Julià, Cecilia Cabrera, Antoni Jou, et al.. (1999). Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy. AIDS. 13(5). 547–555. 17 indexed citations

17.

Goday, Albert, Lidia Ruíz, Manel Juan, et al.. (1999). Efficacy of Low‐Dose Subcutaneous Interleukin‐2 to Treat Advanced Human Immunodeficiency Virus Type 1 in Persons with ⩽250/μL CD4 T Cells and Undetectable Plasma Virus Load. The Journal of Infectious Diseases. 180(1). 56–60. 91 indexed citations

18.

Tural, C., Joan Romeu, Socorro Oros-Ruíz, et al.. (1998). Long‐Lasting Remission of Cytomegalovirus Retinitis without Maintenance Therapy in Human Immunodeficiency Virus‐Infected Patients. The Journal of Infectious Diseases. 177(4). 1080–1083. 146 indexed citations

19.

Rozenbaum, Willy, Antoni Jou, Francesco Castelli, et al.. (1996). Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. AIDS. 10(14). 1627–1633. 26 indexed citations

20.

Gatell, José M., Juan González‐Lahoz, Bonaventura Clotet, et al.. (1996). Switching from Zidovudine to Didanosine in Patients with Symptomatic HIV Infection and Disease Progression. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(3). 249–258. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact